Adaptimmune Therapeutics
ADAP
#9234
Rank
โ‚น6.24 B
Marketcap
โ‚น23.59
Share price
4.45%
Change (1 day)
-75.41%
Change (1 year)

EPS for Adaptimmune Therapeutics (ADAP)

EPS in 2023 (TTM): -โ‚น43.78

According to Adaptimmune Therapeutics's latest financial reports the company's current EPS (TTM) is -โ‚น45.43. In 2022 the company made an earnings per share (EPS) of -โ‚น86.82 a decrease over its 2021 EPS that were of -โ‚น86.82.

EPS history for Adaptimmune Therapeutics from 2016 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-โ‚น43.78-49.57%
2022-โ‚น86.82-0%
2021-โ‚น86.826.25%
2020-โ‚น81.71-27.27%
2019-โ‚น112.3529.41%
2018-โ‚น86.8220.09%
2017-โ‚น72.30-16.73%
2016-โ‚น86.82

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-โ‚น611.98 1,247.12%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น80.01 76.12%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น335.35 638.20%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
โ‚น24.11-153.08%๐Ÿ‡บ๐Ÿ‡ธ USA